Sales rise 14.34% to Rs 122.13 crore
Net profit of Windlas Biotech rose 150.68% to Rs 14.79 crore in the quarter ended March 2022 as against Rs 5.90 crore during the previous quarter ended March 2021. Sales rose 14.34% to Rs 122.13 crore in the quarter ended March 2022 as against Rs 106.81 crore during the previous quarter ended March 2021.For the full year,net profit rose 140.62% to Rs 38.09 crore in the year ended March 2022 as against Rs 15.83 crore during the previous year ended March 2021. Sales rose 8.96% to Rs 465.93 crore in the year ended March 2022 as against Rs 427.60 crore during the previous year ended March 2021.
Click here to connect with us on WhatsApp
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales122.13106.81 14 465.93427.60 9 OPM %11.3310.41 -11.2512.75 - PBDT16.5611.58 43 57.7156.33 2 PBT13.668.23 66 45.5743.36 5 NP14.795.90 151 38.0915.83 141
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
